bpc-157 wiki | Research Grade Peptide BPC-157: The Body Protection Compound

Unlike traditional neurotrophic factors, Dihexa crosses the blood-brain barrier efficiently, resulting in improved learning, memory, and recovery in models of neurodegeneration and traumatic brain injury

A few cross the blood-brain barrier with remarkable efficiency, delivering their signals directly to injured tissue

Neuroplasticity driven by HGF/c-Met signaling includes upregulation of brain-derived neurotrophic factor (BDNF), activation of postsynaptic density protein-95 (PSD-95), and increased expression of GluN2B-containing NMDA receptors

When administered correctly under professional supervision, peptide therapy is generally well-tolerated